Trial · NCT07887932
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of tinnitus phenotypes identified | Baseline | The number of distinct tinnitus phenotypes identified based on demographic characteristics, tinnitus symptoms, audiometric findings, laboratory test results, and comorbidity information recorded in the electronic health records and tinnitus specialty database. |
| Secondary | Tinnitus severity | Baseline | Tinnitus severity measured using the Tinnitus Handicap Inventory (THI), with total scores ranging from 0 to 100. |
| Secondary | Tinnitus loudness | Baseline | Self-reported tinnitus loudness measured using a visual analogue scale (VAS, 0-10). |
| Secondary | Pure-tone hearing thresholds | Baseline | Pure-tone hearing thresholds measured in both ears at 250, 500, 1000, 2000, 4000, and 8000 Hz. |
| Secondary | Tinnitus duration | Baseline | Duration of tinnitus recorded in the electronic health records or tinnitus specialty database. |
| Secondary | Tinnitus laterality | Baseline | Tinnitus laterality recorded as part of the clinical tinnitus assessment. |
| Secondary | White blood cell count | Baseline | White blood cell count obtained from complete blood count testing recorded in the electronic health records. |
| Secondary | Red blood cell count | Baseline | Red blood cell count obtained from complete blood count testing recorded in the electronic health records. |
| Secondary | Haemoglobin concentration | Baseline | Haemoglobin concentration obtained from complete blood count testing recorded in the electronic health records. |
| Secondary | Platelet count | Baseline | Platelet count obtained from complete blood count testing recorded in the electronic health records. |
| Secondary | Differential white blood cell counts | Baseline | Absolute counts or percentages of neutrophils, lymphocytes, monocytes, eosinophils, and basophils, as available in the electronic health records. |
| Secondary | Biochemistry panel | Baseline | Biochemical measurements including liver function, kidney function, blood lipids, blood glucose, and electrolytes. |
| Secondary | Ear CT | Baseline | Findings from ear computed tomography examinations, when available. |
| Secondary | Ear MRI | Baseline | Findings from ear magnetic resonance imaging examinations, when available. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07887932/registered